|
Age (years)
|
55.5 [47–63] (48–63)
|
|
BMI (kg/m2)
|
30.5 [26–33] (27–32)
|
|
Male gender
|
7/16 (43.8%)
|
|
Comorbidities
| |
|
Arterial hypertension
|
5/16 (31.3%)
|
|
CAD
|
1/16 (6.3%)
|
|
COPD
|
1/16 (6.3%)
|
|
Diabetes mellitus
|
4/16 (25%)
|
|
Chronic kidney disease
|
3/16 (18.8%)
|
|
SOFA score at ICU admission
|
11 [06–12] (11–12)
|
|
Invasive mechanical ventilation
|
13/16 (81.3%)
|
|
ICU survival
|
9/16 (56.3%)
|
|
Length of ICU stay (d)
|
26 [18–31] (19–32)
|
|
Steroids before Tocilizumab administration
|
13/16 (81.3%)
|
- Results provided as absolute numbers and (percentages) or as median, [interquartile range] and (95% confidence interval), as appropriate
- BMI body mass index, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, SOFA score sequential organ failure assessment score, ICU; intensive care unit
